AbbVie and Allergan Aesthetics to Present New Data at 2024 Annual AAD Meeting Showcasing Depth and Strength Across Dermatology and Aesthetics Portf...
A total of 29 abstracts, including three late-breaking presentations, demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing science across a spectrum of immune-mediated dermato...
The Top 7 Dividend Stocks to Buy in March 2024
Investors can effectively unlock financial freedom with dividend stocks to buy for a passive income stream. The key to invest in dividend stocks, promising a consistent and growing payout while off...
AbbVie Inc. (ABBV) TD Cowen 44th Annual Health Care Conference (Transcript)
AbbVie Inc. (NYSE:ABBV ) TD Cowen 44th Annual Health Care Conference Call March 5, 2024 9:10 AM ET Company Participants Rob Michael - President, Chief Operating Officer and Incoming CEO Jeff Stewar...
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
Investing in dividend kings is about keeping things simple. A distinguishing feature of these companies is a rock-solid balance sheet that allows them to demonstrate unwavering commitment to buildi...
AbbVie (ABBV) Beats Stock Market Upswing: What Investors Need to Know
In the most recent trading session, AbbVie (ABBV) closed at $178.91, indicating a +1.62% shift from the previous trading day.
Blue-Chip Backbone: 3 Stocks for Unwavering Market Strength
It's often said that patience is a virtue for investors that often means taking advantage of the stability of blue-chip stocks. However, that virtue can be sorely lacking among investors.
Better Dividend Growth Stock: AbbVie or Amgen?
Dividend growth stocks have consistently outshined most other asset classes over the past 124 years. AbbVie and Amgen are two of the brightest stars within the healthcare dividend growth stock land...
OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership
NANTES, France--(BUSINESS WIRE)--OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership.
AbbVie Sees More Than $80 Billion Demand for Bond Sale
AbbVie is selling around $15 billion of bonds in the US investment-grade market to help fund its acquisitions of ImmunoGen and Cerevel Therapeutics Holdings. Olivia Raimonde has more.
AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?
AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024.
AbbVie Names New CEO. The Stock's Not Moving.
Drug maker AbbVie named current President and Chief Operating Officer Robert Michael to succeed Richard Gonzalez as CEO, effective July 1.
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Michael, who is AbbVie's chief operating officer, will become the company's second-ever CEO since the company spun out from Abbott Laboratories in 2013.
AbbVie says Richard Gonzalez to step down as CEO
AbbVie said on Tuesday that Richard Gonzalez will step down from his role as chief executive officer of the drugmaker on July 1.
3 Cash Cows to Boost Your Confidence During the February Chill
What are cash cow stocks? If “Jeopardy!
Related Companies